NCT03452293 - SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

March 28, 2022

Study Completion Date

March 28, 2022

Conditions

PAD

Interventions

DEVICE

Stent Peripheral System

Peripheral PTA with Supera Stent implantation

Trial Locations (15)

35031

Casa di Cura Abano Terme, Abano Terme

49519

Metro Health Hospital, Wyoming

67051

Ospedale di Avezzano, Avezzano

73039

A.O. Cardinale Panico, Tricase

80131

AORN Antonio Cardarelli, Napoli

81024

Clinica San Michele, Maddaloni

91016

Ospedale San Antonio Abate, Erice

95123

A.O.U. Policlinico Vittorio Emanuele, Catania

S2000

Instituto Medico CENICLAR, Unidad Sanatorio de la Mujer, Rosario

06129

A.O.U. Santa Maria della Misericordia, Perugia

00133

Policlinico Tor Vergata, Roma

00184

A.O. San Giovanni Addolorata, Roma

07100

A.O.U. di Sassari, Sassari

05100

Azienda Ospedaliera Santa Maria di Terni, Terni

HA1 3UJ

London North West HealthCare NHS Trust, London

All Listed Sponsors

collaborator

Fondazione Italiana Vascolare

OTHER

lead

EndoCore Lab s.r.l.

OTHER